Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

41 results about "Iopromide" patented technology

Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use. It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs).

Novel synthesis method for iopromide

The invention discloses a novel synthesis method for iopromide. The novel synthesis method comprises the following steps of 1, enabling methoxyacetic acid to react with triphosgene to obtain a reaction product, and then, enabling the reaction production to be directly subjected to one-pot reaction with 5-amino-2, 4, 6-triiodo-isophthalicacyl chloride to prepare a compound 5-[(2-methoxyl) acetamido]-2, 4, 6-triiodo-isophthalicacyl chloride as shown in the formula (II); 2, condensing the compound as shown in the formula (II) and N-methyl-2, 3-dihydroxyl propylamine under the action of a solid catalyst ZrO2-Cr2O3 to obtain a compound 5-[(2-methoxyl) acetamido]-3-(2, 3-dihydroxyl-N-methylpropylaminoformoxyl)-2, 4, 6-triiodo-benzoyl chloride as shown in the formula (III); 3, condensing the compound as shown in the formula (III) and 2, 3-dihydroxylpropylamine under the action of a catalyst to prepare a compound iopromide as shown in the formula (I). The synthesis method for iopromide, disclosed by the invention, is few in byproduct, easy to control the product quality, high in product purity, cheap and easily-obtained in used reagent, few in step, simple in operation, relatively high in total yield and suitable for industrial production, and provides a novel approach for preparing iopromide.
Owner:HUAIHAI INST OF TECH

Efficient contrast agent synthesizing method and application thereof

ActiveCN109134289AIn line with the concept of atomic economicsThere is no special requirement for the order of additionOrganic compound preparationCarboxylic acid amide separation/purificationSynthesis methodsIopromide
The invention discloses an efficient contrast agent synthesizing method. The method includes the following steps of firstly, preparing an intermediate mixture of a compound shown in the formula (II) and a compound shown in the formula (I) and/or (III); secondly, conducting separating to obtain the compound shown in the formula (II) and the compound shown in the formula (I) and/or (III); thirdly, taking the compound shown in the formula (II) to prepare a contrast agent (iopromide); fourthly, taking the compound shown in the formula (III) to prepare a contrast agent (iobitridol), and/or taking the compound shown in the formula (I) to prepare a contrast agent (iohexol, ioversol, iopentol or iodixanol). In the method, the iodic contrast agent is prepared by synthesizing and separating intermediates in the formula (II) and the formula (I) and/or the formula (III) and using the intermediates as the raw materials, the problem that diacylation byproducts need to be removed in an existing method is effectively solved, all the intermediates are effectively used, efficiency is high, and the actual application prospects are good. The formulas (I), (II) and (III) can be seen in the description.
Owner:XILING LAB CO LTD

New method for preparing iopromide

The present invention relates to iopromide preparation methods, and provides three new iopromide preparation methods, wherein the method 1 comprises that a compound represented by a formula II is adopted as a starting raw material and reacts with allylamine to obtain a compound represented by a formula III, the compound represented by the formula III reacts with N-methyl allylamine to obtain a compound represented by a formula IV, the compound represented by the formula IV reacts with methoxyacetyl chloride to obtain a compound represented by a formula V, and the compound represented by the formula V is oxidized to obtain the iopromide represented by a formula I, the method 2 comprises that the compound represented by the formula II is adopted as a starting raw material and reacts with allylamine to obtain the compound represented by the formula III, the compound represented by the formula III reacts with methoxyacetyl chloride to obtain a compound represented by a formula IV-1, the compound represented by the formula IV-1 reacts with N-methyl allylamine to obtain the compound represented by the formula V, and the compound represented by the formula V is oxidized to obtain the iopromide represented by the formula I, the method 3 comprises that the compound represented by the formula II is adopted as a starting raw material and reacts with allylamine to obtain the compound represented by the formula III, the compound represented by the formula III reacts with methoxyacetyl chloride to obtain the compound represented by the formula IV-1, the compound represented by the formula IV-1 reacts with 3-methylamino-1,2-propanediol to obtain a compound represented by a formula V-1, and the compound represented by the formula V-1 is oxidized to obtain the iopromide represented by the formula I, and the method 4 comprises that the compound represented by the formula II is adopted as a starting raw material and reacts with methoxyacetyl chloride obtain a compound represented by a formula III-1, the compound represented by the formula III-1 reacts with allylamine to obtain the compound represented by the formula IV-1, the compound represented by the formula IV-1 reacts with N-methyl allylamine to obtain the compound represented by the formula V, and the compound represented by the formula V is oxidized to obtain the iopromide represented by the formula I.
Owner:SHENYANG J & HEALTH PHARMA

Iopromide decoloring and purifying process

The invention relates to an iopromide decoloring and purifying process, mainly solving the technical problems of low yield, waste water environment pollution and the like and belonging to the technical field of chemical synthesis, separation and purification. The iopromide decoloring and purifying process is characterized by comprising the following steps of: weighing an iopromide crude product with the purity of 95%-98%, stirring to dissolve in deionized water until the concentration is 100-250 mg/ml, and filtering to remove impurities; then continuously flowing through a chromatographic column with macroporous polystyrene-divinylbenzene microsphere resin as a chromatographic packing at the flow velocity of 1-4 times of column volume per hour, wherein the ratio of the volume L of the macroporous polystyrene-divinylbenzene microsphere resin and the weight g of a sample is (1:10)-(1:80); eluting by using the deionized water as a mobile phase, collecting eluent with the purity of more than 99%, concentrating by using a nanofiltration membrane, and carrying out spray drying. According to the iopromide decoloring and purifying process, the chromatographic packing has the advantages of large adsorption quantity, good selectivity and the like; an iopromide product with the purity of 99% and the yield more than 90% can be obtained through one-time operation by eluting through the deionized water. The iopromide decoloring and purifying process disclosed by the invention has the advantages of simple process, high efficiency, easiness for industrialized production, less environmental pollution and the like.
Owner:上海华震科技有限公司

Drying machine for iopromide processing

The invention discloses a drying machine for iopromide processing, which comprises a vertical plate, the upper portion of the front end face of the vertical plate is rotatably connected with the front end face of a box body through a pin shaft, a transverse plate is arranged above the box body, a drying structure is arranged above the transverse plate, and the drying structure comprises a motor I, gears, a chain, a straight block, an annular plate, a belt, a bent plate, a sliding block I and a drying machine. According to the drying machine for the iopromide processing provided by the invention, through cooperation of a bottom plate, a straight plate, a transverse plate, a shell II, a first shell, the vertical plate, the box body and the drying structure, the motor I drives the gears on one side to rotate, the chain enables the two gears to rotate at the same time, then the chain rotates, the chain drives the belt to rotate, the belt drives the straight block to rotate, the straight block drives the annular plate to move left and right, the annular plate drives the sliding block I to move left and right, the sliding block I drives the drying machine to move left and right, then the drying machine moves left and right, the drying effect of iopromide is more uniform, and the drying effect is improved.
Owner:东莞市丰泽精密模具有限公司

Visual absolute ethyl alcohol-iopromide composite hardening injection as well as preparation method and application thereof

The invention provides a visual absolute ethyl alcohol-iopromide composite hardening injection. The visual absolute ethyl alcohol-iopromide composite hardening injection comprises absolute ethyl alcohol and iopromide, and the volume fraction of ethyl alcohol in the composite hardening injection is 99.5% at the temperature of 15 DEG C. The invention also provides a preparation method of the visual absolute ethyl alcohol-iopromide composite hardening injection. The method comprises the following steps: mixing iopromide powder with a proper amount of absolute ethyl alcohol, and stirring to uniformly disperse to obtain an iopromide-absolute ethyl alcohol suspension; and adding absolute ethyl alcohol to fix the volume, so that the volume fraction of the ethyl alcohol of the prepared composite hardening injection at 15 DEG C is 99.5%. According to the composite hardening injection, the flow direction of the absolute ethyl alcohol is dynamically monitored in the embolism hardening process, accurate and visual treatment is achieved, the treatment risk and complications are reduced, and the X-ray radiation resistance of the composite preparation can be adjusted by adjusting the content of iopromide added into the absolute ethyl alcohol according to specific treatment requirements.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Filter for iopromide processing

The invention discloses a filter for iopromide processing. The filter comprises a support, wherein a box body is fixedly arranged on the inner wall of the support, a transverse plate is fixedly arranged on one side of the rear end of the support, a filtering structure is arranged above the transverse plate, the filtering structure comprises a first round plate, a round rod, a bent rod, a round block, a wide plate, a short rod, a first motor, a filter screen, a first sliding block and a first sliding rod, and the bottom of the first motor is fixedly connected with the top of the transverse plate. According to the filter for iopromide processing, through cooperation of a bottom plate, a square box, a support, the box body, a first shell, the transverse plate, a second shell and the filtering structure, the first motor drives the first round plate to rotate, the first round plate drives the round rod to rotate, the round rod drives the bent rod to rotate, the bent rod drives the round block to move leftwards, then the round rod drives the short rod to move rightwards, then the wide plate moves leftwards and rightwards, and the wide plate drives the filter screen to move left and right, so that a worker can conveniently move the filter screen left and right, the filtering rate of iopromide is increased, and the working efficiency is improved.
Owner:东莞市盈通环保科技有限公司

New method for preparing iopromide

The present invention relates to iopromide preparation methods, and provides three new iopromide preparation methods, wherein the method 1 comprises that a compound represented by a formula II is adopted as a starting raw material and reacts with allylamine to obtain a compound represented by a formula III, the compound represented by the formula III reacts with N-methyl allylamine to obtain a compound represented by a formula IV, the compound represented by the formula IV reacts with methoxyacetyl chloride to obtain a compound represented by a formula V, and the compound represented by the formula V is oxidized to obtain the iopromide represented by a formula I, the method 2 comprises that the compound represented by the formula II is adopted as a starting raw material and reacts with allylamine to obtain the compound represented by the formula III, the compound represented by the formula III reacts with methoxyacetyl chloride to obtain a compound represented by a formula IV-1, the compound represented by the formula IV-1 reacts with N-methyl allylamine to obtain the compound represented by the formula V, and the compound represented by the formula V is oxidized to obtain the iopromide represented by the formula I, the method 3 comprises that the compound represented by the formula II is adopted as a starting raw material and reacts with allylamine to obtain the compound represented by the formula III, the compound represented by the formula III reacts with methoxyacetyl chloride to obtain the compound represented by the formula IV-1, the compound represented by the formula IV-1 reacts with 3-methylamino-1,2-propanediol to obtain a compound represented by a formula V-1, and the compound represented by the formula V-1 is oxidized to obtain the iopromide represented by the formula I, and the method 4 comprises that the compound represented by the formula II is adopted as a starting raw material and reacts with methoxyacetyl chloride obtain a compound represented by a formula III-1, the compound represented by the formula III-1 reacts with allylamine to obtain the compound represented by the formula IV-1, the compound represented by the formula IV-1 reacts with N-methyl allylamine to obtain the compound represented by the formula V, and the compound represented by the formula V is oxidized to obtain the iopromide represented by the formula I.
Owner:SHENYANG J & HEALTH PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products